The preproliferative stage in type 2 macular telangiectasia (MacTel type 2)

[1] CharbelIssa P(2013)Macular telangiectasia type 2 Prog Retin Eye Res 34 49-77

[2] Gillies MC(1993)Idiopathic juxtafoveolar retinal telangiectasis. Update of classification and follow-up study Ophthalmology 100 1536-1546

[3] Chew EY(2014)Macular telangiectasia type 2: the international MacTel project Ophthalmol Z Dtsch Ophthalmol Ges 111 817-818

[4] Gass JD(1960)(2006) Idiopathic macular telangiectasia Arch Ophthalmol Chic Ill 124 450-460

[5] Blodi BA(2020)Non-proliferative type II macular telangiectasia variant with subfoveal detachment: role of anti-VEGF therapy Br J Ophthalmol 104 1216-1222

[6] CharbelIssa P(2019)Epiretinal neovascularization: a novel OCT angiography finding in macular telangiectasia type 2 Ophthalmol Retina 3 516-522

[7] Pauleikhoff D(2020)Real-world outcomes of intravitreal anti-vascular endothelial growth factor monotherapy in proliferative type 2 macular telangiectasia Graefes Arch Clin Exp Ophthalmol Albrecht Von Graefes Arch Klin Exp Ophthalmol 86 464-465

[8] Holz FG(2008)A new diagnostic approach in patients with type 2 macular telangiectasia: confocal reflectance imaging Acta Ophthalmol (Copenh) 67 105-108

[9] Yannuzzi LA(2019)Response to anti-vascular endothelial growth factor of abnormal retinal vascular net in para foveal telangiectasia group II images on optical coherence tomography-angiography Indian J Ophthalmol 49 1172-1177

[10] Bardal AMC(2008)Confocal blue reflectance imaging in type 2 idiopathic macular telangiectasia Invest Ophthalmol Vis Sci 58 536-559

[1] CharbelIssa P(2013)Macular telangiectasia type 2 Prog Retin Eye Res 34 49-77

[2] Gillies MC(1993)Idiopathic juxtafoveolar retinal telangiectasis. Update of classification and follow-up study Ophthalmology 100 1536-1546

[3] Chew EY(2014)Macular telangiectasia type 2: the international MacTel project Ophthalmol Z Dtsch Ophthalmol Ges 111 817-818

[4] Gass JD(1960)(2006) Idiopathic macular telangiectasia Arch Ophthalmol Chic Ill 124 450-460

[5] Blodi BA(2020)Non-proliferative type II macular telangiectasia variant with subfoveal detachment: role of anti-VEGF therapy Br J Ophthalmol 104 1216-1222

[6] CharbelIssa P(2019)Epiretinal neovascularization: a novel OCT angiography finding in macular telangiectasia type 2 Ophthalmol Retina 3 516-522

[7] Pauleikhoff D(2020)Real-world outcomes of intravitreal anti-vascular endothelial growth factor monotherapy in proliferative type 2 macular telangiectasia Graefes Arch Clin Exp Ophthalmol Albrecht Von Graefes Arch Klin Exp Ophthalmol 86 464-465

[8] Holz FG(2008)A new diagnostic approach in patients with type 2 macular telangiectasia: confocal reflectance imaging Acta Ophthalmol (Copenh) 67 105-108

[9] Yannuzzi LA(2019)Response to anti-vascular endothelial growth factor of abnormal retinal vascular net in para foveal telangiectasia group II images on optical coherence tomography-angiography Indian J Ophthalmol 49 1172-1177

[10] Bardal AMC(2008)Confocal blue reflectance imaging in type 2 idiopathic macular telangiectasia Invest Ophthalmol Vis Sci 58 536-559